Anti-CNTNAP1 monoclonal antibody

Pre-made anti-CNTNAP1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CNTNAP1/CNTNAP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0586-Ab-1/ GM-Tg-hg-IP0586-Ab-2Anti-Human CNTNAP1 monoclonal antibodyHuman
GM-Tg-rg-IP0586-Ab-1/ GM-Tg-rg-IP0586-Ab-2Anti-Rat CNTNAP1 monoclonal antibodyRat
GM-Tg-mg-IP0586-Ab-1/ GM-Tg-mg-IP0586-Ab-2Anti-Mouse CNTNAP1 monoclonal antibodyMouse
GM-Tg-cynog-IP0586-Ab-1/ GM-Tg-cynog-IP0586-Ab-2Anti-Cynomolgus/ Rhesus macaque CNTNAP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0586-Ab-1/ GM-Tg-felg-IP0586-Ab-2Anti-Feline CNTNAP1 monoclonal antibodyFeline
GM-Tg-cang-IP0586-Ab-1/ GM-Tg-cang-IP0586-Ab-2Anti-Canine CNTNAP1 monoclonal antibodyCanine
GM-Tg-bovg-IP0586-Ab-1/ GM-Tg-bovg-IP0586-Ab-2Anti-Bovine CNTNAP1 monoclonal antibodyBovine
GM-Tg-equg-IP0586-Ab-1/ GM-Tg-equg-IP0586-Ab-2Anti-Equine CNTNAP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0586-Ab-1/ GM-Tg-hg-IP0586-Ab-2; GM-Tg-rg-IP0586-Ab-1/ GM-Tg-rg-IP0586-Ab-2;
GM-Tg-mg-IP0586-Ab-1/ GM-Tg-mg-IP0586-Ab-2; GM-Tg-cynog-IP0586-Ab-1/ GM-Tg-cynog-IP0586-Ab-2;
GM-Tg-felg-IP0586-Ab-1/ GM-Tg-felg-IP0586-Ab-2; GM-Tg-cang-IP0586-Ab-1/ GM-Tg-cang-IP0586-Ab-2;
GM-Tg-bovg-IP0586-Ab-1/ GM-Tg-bovg-IP0586-Ab-2; GM-Tg-equg-IP0586-Ab-1/ GM-Tg-equg-IP0586-Ab-2
Products NameAnti-CNTNAP1 monoclonal antibody
Formatmab
Target NameCNTNAP1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CNTNAP1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0586-Ag-1Recombinant multi-species CNTP1/ CNTNAP1/ CASPR protein


    Target information

    Target IDGM-IP0586
    Target NameCNTNAP1
    Gene ID8506,53321,84008,574229,490960,101099341,540997,100052467
    Gene Symbol and SynonymsCASPR,CHN3,CNTNAP,CNTNAP1,NCP1,NRXN4,P190,shm
    Uniprot AccessionP78357,P97846
    Uniprot Entry NameCNTP1_HUMAN,CNTP1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000108797
    Target ClassificationN/A

    The target: CNTNAP1, gene name: CNTNAP1, also named as CASPR, CNTNAP, NRXN4, P190. The gene product was initially identified as a 190-kD protein associated with the contactin-PTPRZ1 complex. The 1,384-amino acid protein, also designated p190 or CASPR for 'contactin-associated protein,' includes an extracellular domain with several putative protein-protein interaction domains, a putative transmembrane domain, and a 74-amino acid cytoplasmic domain. Northern blot analysis showed that the gene is transcribed predominantly in brain as a transcript of 6.2 kb, with weak expression in several other tissues tested. The architecture of its extracellular domain is similar to that of neurexins, and this protein may be the signaling subunit of contactin, enabling recruitment and activation of intracellular signaling pathways in neurons. [provided by RefSeq, Jan 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.